Matches in Wikidata for { <http://www.wikidata.org/entity/Q57995793> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q57995793 description "article" @default.
- Q57995793 description "im Februar 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57995793 description "wetenschappelijk artikel" @default.
- Q57995793 description "наукова стаття, опублікована в грудні 2007" @default.
- Q57995793 name "Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance" @default.
- Q57995793 name "Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance" @default.
- Q57995793 type Item @default.
- Q57995793 label "Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance" @default.
- Q57995793 label "Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance" @default.
- Q57995793 prefLabel "Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance" @default.
- Q57995793 prefLabel "Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance" @default.
- Q57995793 P1433 Q57995793-03BD3599-2AA6-4C57-AFB4-B4D5BB3EFF00 @default.
- Q57995793 P1476 Q57995793-41EE03A9-740E-4F48-A2D9-9A620BA77EFE @default.
- Q57995793 P2093 Q57995793-23C23C83-1EB3-4610-9453-571E694DD744 @default.
- Q57995793 P2093 Q57995793-A6932D10-D57E-4092-9705-0A27F904083B @default.
- Q57995793 P304 Q57995793-4BE9C721-4668-4FCD-A674-8ACAE3F1D7AD @default.
- Q57995793 P31 Q57995793-4e04a175-43d3-4a84-955d-f439010a69bf @default.
- Q57995793 P31 Q57995793-719AC2C6-2140-410C-A27B-669ACFEC3BFC @default.
- Q57995793 P356 Q57995793-8A800C8A-53C3-463F-8F85-0748E35FAB0C @default.
- Q57995793 P433 Q57995793-C1E0BE9F-FCE1-4B93-A323-E512B6D9448D @default.
- Q57995793 P478 Q57995793-FFFF8BBD-EC92-4B1B-A2D9-5D6AC44E48B0 @default.
- Q57995793 P50 Q57995793-5AEC7873-2BA4-4DFF-A188-4E9B7305B5C3 @default.
- Q57995793 P577 Q57995793-E259B87D-0B05-4CA3-AD25-81BBDA697DF2 @default.
- Q57995793 P698 Q57995793-9CCB5F43-AA5C-4804-A805-4D3623DEF369 @default.
- Q57995793 P921 Q57995793-5860FBDC-494B-4DDD-AB73-48F2B317F318 @default.
- Q57995793 P921 Q57995793-7242A342-08CA-4E91-A295-C7F734127011 @default.
- Q57995793 P921 Q57995793-A31E848B-546C-42E4-928E-408809A50990 @default.
- Q57995793 P356 KEM294 @default.
- Q57995793 P698 18208819 @default.
- Q57995793 P1433 Q7320492 @default.
- Q57995793 P1476 "Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance" @default.
- Q57995793 P2093 "Allan Wailoo" @default.
- Q57995793 P2093 "Jim Chilcott" @default.
- Q57995793 P304 "119-120" @default.
- Q57995793 P31 Q13442814 @default.
- Q57995793 P31 Q871232 @default.
- Q57995793 P356 "10.1093/RHEUMATOLOGY/KEM294" @default.
- Q57995793 P433 "2" @default.
- Q57995793 P478 "47" @default.
- Q57995793 P50 Q37838997 @default.
- Q57995793 P577 "2008-02-01T00:00:00Z" @default.
- Q57995793 P698 "18208819" @default.
- Q57995793 P921 Q1754768 @default.
- Q57995793 P921 Q348260 @default.
- Q57995793 P921 Q52849 @default.